IPO
-
Expert warns of tax risks in using pre-IPO AI stock for home purchases
San Jose State University tech expert Ahmed Banafa has a warning for anyone tempted to swap pre-IPO shares for a house: the…
Most read
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Experimental Drug Combo Doubles One-Year Survival Rates in Pancreatic Cancer Trial
-
Factor XIa Inhibitor Asundexian Cuts Recurrent Stroke Risk Without Raising Major Bleeding
-
UCSF Scientists Eliminate Deadly Brain Tumors in Mice with B-SYNC Therapy
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Why Achieve Says Most Americans Feel Their Financial Stability is Slipping Away
-
Locking In High Yields: How Current CD Rates Offer Safe Returns Amid Shifting Economic Outlooks
-
Medicare Denies $949 Multi-Cancer Blood Test, Leaving Seniors With Full Bill Until 2029
-
India’s NPPA slashes 137 cancer drug prices by up to 96%, saving ₹3,500 crore annually
-
Inside AbbVie’s High-Stakes Neuro Portfolio and Pipeline Strategy
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992